# BrainsWay Announces FDA Approval of Neurolief's ProlivTMRx Neuromodulation System for Major Depressive Disorder (MDD)

- URL: https://theranews.net/blog/2026-01-13-brainsway-announces-fda-approval-of-neuroliefs-prolivtmrx-neuromodulation-system-6da459/
- Published: 2026-01-13
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: benzinga
- Original report: https://www.benzinga.com/pressreleases/26/01/g49839001/brainsway-announces-fda-approval-of-neuroliefs-proliv-rx-neuromodulation-system-for-major-depressi
- Topics: depression
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> BURLINGTON, Mass. and JERUSALEM, Jan. 12, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Appro

---
![BrainsWay Announces FDA Approval of Neurolief's ProlivTMRx Neuromodulation System for Major Depressive Disorder (MDD)](/uploads/news-images/brainsway-announces-fda-approval-of-neurolief-s-pr-20260113110044.jpeg)

---
*Originally reported by benzinga. [Read more](https://www.benzinga.com/pressreleases/26/01/g49839001/brainsway-announces-fda-approval-of-neuroliefs-proliv-rx-neuromodulation-system-for-major-depressi)*

---

*Source: [https://www.benzinga.com/pressreleases/26/01/g49839001/brainsway-announces-fda-approval-of-neuroliefs-proliv-rx-neuromodulation-system-for-major-depressi](https://www.benzinga.com/pressreleases/26/01/g49839001/brainsway-announces-fda-approval-of-neuroliefs-proliv-rx-neuromodulation-system-for-major-depressi)*